Risk Of Contralateral Breast Cancer Is Falling
Risk Of Contralateral Breast Cancer Is Falling Contralateral (opposite) breast cancer has declined annually in the USA by approximately 3% from the mid-1980s to 2006. Multiple explanations have been put forth, including the use of tamoxifen in the 1980s and 90s, aromatase inhibitors (anastrozole, letrozole, exemestane) in the early 2000s, a shift toward taxanes (Taxol…